Literature DB >> 16827760

Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?

Esa van den Akker1, D Oepkes, A Brand, H H H Kanhai.   

Abstract

OBJECTIVES: To evaluate the safety of vaginal delivery in pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT).
DESIGN: Prospective data collection.
SETTING: Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation. POPULATION: Thirty-two pregnancies with FNAIT, with a sibling with thrombocytopenia but without an intracranial haemorrhage (ICH).
METHODS: The mode of delivery, platelet count in cord blood and neonatal outcome were analysed. All women received weekly intravenous immunoglobulin from 32 to 38 weeks of gestation. Head ultrasound scan was performed in all neonates. MAIN OUTCOME MEASURES: Signs of ICH or other bleeding in the neonates.
RESULTS: Twenty-three women delivered vaginally. Nine caesarean sections were performed, all for obstetric reasons. Median platelet count at birth was 142 x 10(9)/l (range, 4-252 x 10(9)/l), with severe thrombocytopenia (<50 x10(9)/l) in four neonates, of which three were born vaginally. None of the neonates showed signs of ICH or other bleeding.
CONCLUSIONS: In pregnancies with FNAIT and a thrombocytopenic sibling without ICH, vaginal delivery was not associated with neonatal intracranial bleeding. These initial results support our noninvasive management of these pregnancies with FNAIT.

Entities:  

Mesh:

Year:  2006        PMID: 16827760     DOI: 10.1111/j.1471-0528.2006.00993.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

1.  Neonatal Alloimmune Thrombocytopenia: A Report of Four Cases.

Authors:  Mizuki Uenaka; Mayumi Morizane; Kenji Tanimura; Masashi Deguchi; Yasuhiko Ebina; Makoto Hashimoto; Ichiro Morioka; Hideto Yamada
Journal:  Kobe J Med Sci       Date:  2019-03-05

Review 2.  Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Authors:  Heidi Tiller; Anne Husebekk; Maria Therese Ahlen; Tor B Stuge; Bjørn Skogen
Journal:  Int J Womens Health       Date:  2017-04-19

3.  Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.

Authors:  Sandra Wienzek-Lischka; Angelika Sawazki; Harald Ehrhardt; Ulrich J Sachs; Roland Axt-Fliedner; Gregor Bein
Journal:  Arch Gynecol Obstet       Date:  2020-06-04       Impact factor: 2.344

4.  Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry.

Authors:  Heidi Tiller; Marije M Kamphuis; Olof Flodmark; Nikos Papadogiannakis; Anna L David; Susanna Sainio; Sinikka Koskinen; Kaija Javela; Agneta Taune Wikman; Riitta Kekomaki; Humphrey H H Kanhai; Dick Oepkes; Anne Husebekk; Magnus Westgren
Journal:  BMJ Open       Date:  2013-03-22       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.